Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Wynn Volkert

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Concepts & Ideas

Tissue Distribution

Chemicals & Drugs

Living Beings

Procedures

Isotope Labeling

Anatomy

Brain

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
40
Hoffman, Timothy
18
Sieckman, Gary
14
Katti, Kattesh
13
Ketring, Alan
11
Owen, Nellie
11
Gali, Hariprasad
8
Higginbotham, Chris
7
Forte, Leonard
7
Smith, Jeffrey
5
Jurisson, Silvia
4
Mazuru, Dana
4
Pillarsetty, Nagavarakishore
4
Figueroa, Said Daibes
4
Hayes, Donald
4
Giblin, Michael

Sign-in to see all Coauthors

Publications

TOP 3
Liu Dijie; Overbey Douglas; Watkinson Lisa D; Daibes-Figueroa Said; Hoffman Timothy J; Forte Leonard R; Volkert Wynn A; Giblin Michael F
In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone.
Figueroa Said Daibes; Winkelmann Christopher T; Miller H William; Volkert Wynn A; Hoffman Timothy J
TLD assessment of mouse dosimetry during microCT imaging.
Garrison Jered C; Rold Tammy L; Sieckman Gary L; Naz Farah; Sublett Samantha V; Figueroa Said Daibes; Volkert Wynn A; Hoffman Timothy J
Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Wynn Volkert (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Liu Dijie; Overbey Douglas; Watkinson Lisa D; Daibes-Figueroa Said; Hoffman Timothy J; Forte Leonard R; Volkert Wynn A; Giblin Michael F
In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin peptide hormone.
Anticancer research 2009;29(10):3777-83.
2008: Figueroa Said Daibes; Winkelmann Christopher T; Miller H William; Volkert Wynn A; Hoffman Timothy J
TLD assessment of mouse dosimetry during microCT imaging.
Medical physics 2008;35(9):3866-74.
2008: Garrison Jered C; Rold Tammy L; Sieckman Gary L; Naz Farah; Sublett Samantha V; Figueroa Said Daibes; Volkert Wynn A; Hoffman Timothy J
Evaluation of the pharmacokinetic effects of various linking group using the 111In-DOTA-X-BBN(7-14)NH2 structural paradigm in a prostate cancer model.
Bioconjugate chemistry 2008;19(9):1803-12.
2008: Eckelman William C; Bonardi Mauro; Volkert Wynn A
True radiotracers: are we approaching theoretical specific activity with Tc-99m and I-123?
Nuclear medicine and biology 2008;35(5):523-7.
2007: Garrison Jered C; Rold Tammy L; Sieckman Gary L; Figueroa Said Daibes; Volkert Wynn A; Jurisson Silvia S; Hoffman Timothy J
In vivo evaluation and small-animal PET/CT of a prostate cancer mouse model using 64Cu bombesin analogs: side-by-side comparison of the CB-TE2A and DOTA chelation systems.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2007;48(8):1327-37.
2007: Ma Lixin; Yu Ping; Veerendra Bhadrasetty; Rold Tammy L; Retzloff Lauren; Prasanphanich Adam; Sieckman Gary; Hoffman Timothy J; Volkert Wynn A; Smith Charles J
In vitro and in vivo evaluation of Alexa Fluor 680-bombesin[7-14]NH2 peptide conjugate, a high-affinity fluorescent probe with high selectivity for the gastrin-releasing peptide receptor.
Molecular imaging : official journal of the Society for Molecular Imaging 2007;6(3):171-80.
2006: Giblin Michael F; Sieckman Gary L; Watkinson Lisa D; Daibes-Figueroa Said; Hoffman Timothy J; Forte Leonard R; Volkert Wynn A
Selective targeting of E. coli heat-stable enterotoxin analogs to human colon cancer cells.
Anticancer research 2006;26(5A):3243-51.
2006: Giblin Michael F; Gali Hariprasad; Sieckman Gary L; Owen Nellie K; Hoffman Timothy J; Volkert Wynn A; Forte Leonard R
In vitro and in vivo evaluation of 111In-labeled E. coli heat-stable enterotoxin analogs for specific targeting of human breast cancers.
Breast cancer research and treatment 2006;98(1):7-15.
2006: Giblin Michael F; Sieckman Gary L; Shelton Tiffani D; Hoffman Timothy J; Forte Leonard R; Volkert Wynn A
In vitro and in vivo evaluation of 177Lu- and 90Y-labeled E. coli heat-stable enterotoxin for specific targeting of uroguanylin receptors on human colon cancers.
Nuclear medicine and biology 2006;33(4):481-8.
2006: Winkelmann Christopher T; Figueroa Said Daibes; Rold Tammy L; Volkert Wynn A; Hoffman Timothy J
Microimaging characterization of a B16-F10 melanoma metastasis mouse model.
Molecular imaging : official journal of the Society for Molecular Imaging 2006;5(2):105-14.
2006: Johnson Christopher V; Shelton Tiffani; Smith Charles J; Ma Lixin; Perry Michael C; Volkert Wynn A; Hoffman Timothy J
Evaluation of combined (177)Lu-DOTA-8-AOC-BBN (7-14)NH(2) GRP receptor-targeted radiotherapy and chemotherapy in PC-3 human prostate tumor cell xenografted SCID mice.
Cancer biotherapy & radiopharmaceuticals 2006;21(2):155-66.
2005: Smith Charles J; Volkert Wynn A; Hoffman Timothy J
Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.
Nuclear medicine and biology 2005;32(7):733-40.
2005: Miller William H; Hartmann-Siantar Christine; Fisher Darrell; Descalle Marie-Anne; Daly Tom; Lehmann Joerg; Lewis Michael R; Hoffman Timothy; Smith Jeff; Situ Peter D; Volkert Wynn A
Evaluation of beta-absorbed fractions in a mouse model for 90Y, 188Re, 166Ho, 149Pm, 64Cu, and 177Lu radionuclides.
Cancer biotherapy & radiopharmaceuticals 2005;20(4):436-49.
2004: Giblin Michael F; Gali Hariprasad; Sieckman Gary L; Owen Nellie K; Hoffman Timothy J; Forte Leonard R; Volkert Wynn A
In vitro and in vivo comparison of human Escherichia coli heat-stable peptide analogues incorporating the 111In-DOTA group and distinct linker moieties.
Bioconjugate chemistry 2004;15(4):872-80.
2003: Smith C J; Volkert W A; Hoffman T J
Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.
Nuclear medicine and biology 2003;30(8):861-8.
2003: Smith C Jeffrey; Sieckman Gary L; Owen Nellie K; Hayes Donald L; Mazuru Dana G; Kannan Raghuraman; Volkert Wynn A; Hoffman Timothy J
Radiochemical investigations of gastrin-releasing peptide receptor-specific [(99m)Tc(X)(CO)3-Dpr-Ser-Ser-Ser-Gln-Trp-Ala-Val-Gly-His-Leu-Met-(NH2)] in PC-3, tumor-bearing, rodent models: syntheses, radiolabeling, and in vitro/in vivo studies where Dpr = 2,3-diaminopropionic acid and X = H2O or P(CH2OH)3.
Cancer research 2003;63(14):4082-8.
2003: Kothari K K; Raghuraman K; Pillarsetty N K; Hoffman T J; Owen N K; Katti K V; Volkert W A
Syntheses, in vitro and in vivo characterization of a 99mTc-(I)-tricarbonyl-benzylamino-dihydroxymethyl phosphine (NP(2)) chelate.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 2003;58(5):543-9.
2003: Hoffman Timothy J; Gali Hariprasad; Smith C Jeffrey; Sieckman Gary L; Hayes Donald L; Owen Nellie K; Volkert Wynn A
Novel series of 111In-labeled bombesin analogs as potential radiopharmaceuticals for specific targeting of gastrin-releasing peptide receptors expressed on human prostate cancer cells.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2003;44(5):823-31.
2003: Pillarsetty Nagavarakishore; Katti Kavita K; Hoffman Timothy J; Volkert Wynn A; Katti Kattesh V; Kamei Hideo; Koide Tatsurou
In vitro and in vivo antitumor properties of tetrakis((trishydroxy- methyl)phosphine)gold(I) chloride.
Journal of medicinal chemistry 2003;46(7):1130-2.
2003: Smith C Jeffrey; Gali Hariprasad; Sieckman Gary L; Hayes Donald L; Owen Nellie K; Mazuru Dana G; Volkert Wynn A; Hoffman Timothy J
Radiochemical investigations of 177Lu-DOTA-8-Aoc-BBN[7-14]NH2: an in vitro/in vivo assessment of the targeting ability of this new radiopharmaceutical for PC-3 human prostate cancer cells.
Nuclear medicine and biology 2003;30(2):101-9.
2003: Smith C Jeffrey; Sieckman Gary L; Owen Nellie K; Hayes Donald L; Mazuru Dana G; Volkert Wynn A; Hoffman Timothy J
Radiochemical investigations of [188Re(H2O)(CO)3-diaminopropionic acid-SSS-bombesin(7-14)NH2]: syntheses, radiolabeling and in vitro/in vivo GRP receptor targeting studies.
Anticancer research 2003;23(1A):63-70.
2003: Smith C Jeffrey; Gali Hariprasad; Sieckman Gary L; Higginbotham Chris; Volkert Wynn A; Hoffman Timothy J
Radiochemical investigations of (99m)Tc-N(3)S-X-BBN[7-14]NH(2): an in vitro/in vivo structure-activity relationship study where X = 0-, 3-, 5-, 8-, and 11-carbon tethering moieties.
Bioconjugate chemistry 2003;14(1):93-102.
2002: Rajagopalan Raghavan; Kuntz Robert R; Sharma Uday; Volkert Wynn A; Pandurangi Raghoottama S
Chemistry of bifunctional photoprobes. 6. Synthesis and characterization of high specific activity metalated photochemical probes: development of novel rhenium photoconjugates of human serum albumin and fab fragments.
The Journal of organic chemistry 2002;67(19):6748-57.
2002: Raghuraman Kannan; Pillarsetty Nagavarakishore; Volkert Wynn A; Barnes Charles; Jurisson Silvia; Katti Kattesh V
Exceptional kinetic propensity of hydroxymethyl phosphanes toward Rh(III) stabilization in water.
Journal of the American Chemical Society 2002;124(25):7276-7.
2002: Hu Fang; Cutler Cathy S; Hoffman Timothy; Sieckman Gary; Volkert Wynn A; Jurisson Silvia S
Pm-149 DOTA bombesin analogs for potential radiotherapy. in vivo comparison with Sm-153 and Lu-177 labeled DO3A-amide-betaAla-BBN(7-14)NH(2).
Nuclear medicine and biology 2002;29(4):423-30.
2002: Gali Hariprasad; Sieckman Gary L; Hoffman Timothy J; Owen Nellie K; Mazuru Dana G; Forte Leonard R; Volkert Wynn A
Chemical synthesis of Escherichia coli ST(h) analogues by regioselective disulfide bond formation: biological evaluation of an (111)In-DOTA-Phe(19)-ST(h) analogue for specific targeting of human colon cancers.
Bioconjugate chemistry 2002;13(2):224-31.
2002: Kothari K K; Gali H; Prabhu K R; Pillarsetty N; Owen N K; Katti K V; Hoffman T J; Volkert W A
Synthesis and characterization of (99m)Tc- and (188)Re-complexes with a diamido-dihydroxymethylenephosphine-based bifunctional chelating agent (N(2)P(2)-BFCA).
Nuclear medicine and biology 2002;29(1):83-9.
2001: Gali H; Sieckman G L; Hoffman T J; Owen N K; Chin D T; Forte L R; Volkert W A
In vivo evaluation of an 111In-labeled ST-peptide analog for specific-targeting of human colon cancers.
Nuclear medicine and biology 2001;28(8):903-9.
2001: Gali H; Sieckman G L; Hoffman T J; Kiefer G E; Chin D T; Forte L R; Volkert W A
Synthesis and in vitro evaluation of an 111In-labeled ST-peptide enterotoxin (ST) analogue for specific targeting of guanylin receptors on human colonic cancers.
Anticancer research 2001;21(4A):2785-92.
2001: Hoffman T J; Quinn T P; Volkert W A
Radiometallated receptor-avid peptide conjugates for specific in vivo targeting of cancer cells.
Nuclear medicine and biology 2001;28(5):527-39.
2001: Gali H; Hoffman T J; Sieckman G L; Owen N K; Katti K V; Volkert W A
Synthesis, characterization, and labeling with 99mTc/188Re of peptide conjugates containing a dithia-bisphosphine chelating agent.
Bioconjugate chemistry 2001;12(3):354-63.
2001: Schibli R; Katti K V; Volkert W A; Barnes C L
Development of novel water-soluble, organometallic compounds for potential use in nuclear medicine: synthesis, characterization, and (1)H and (31)P NMR investigations of the complexes fac-[ReBr(CO)3L] (L=bis(bis(hydroxymethyl)phosphino)ethane, bis(bis(hydroxymethyl)phosphino)benzene).
Inorganic chemistry 2001;40(10):2358-62.
1999: Goswami N; Higginbotham C; Volkert W; Alberto R; Nef W; Jurisson S
Rhodium-105 tetrathioether complexes: radiochemistry and initial biological evaluation.
Nuclear medicine and biology 1999;26(8):951-7.
1999: Schibli R; Katti K V; Higginbotham C; Volkert W A; Alberto R
In vitro and in vivo evaluation of bidentate, water-soluble phosphine ligands as anchor groups for the organometallic fac-[99mTc(CO)3]+-core.
Nuclear medicine and biology 1999;26(6):711-6.
1999: Karra S R; Schibli R; Gali H; Katti K V; Hoffman T J; Higginbotham C; Sieckman G L; Volkert W A
99mTc-labeling and in vivo studies of a bombesin analogue with a novel water-soluble dithiadiphosphine-based bifunctional chelating agent.
Bioconjugate chemistry 1999;10(2):254-60.
1998: Berning D E; Katti K V; Volkert W A; Higginbotham C J; Ketring A R
198Au-labeled hydroxymethyl phosphines as models for potential therapeutic pharmaceuticals.
Nuclear medicine and biology 1998;25(6):577-83.
1997: Smith C J; Li N; Katti K V; Higginbotham C; Volkert W A
In vitro and in vivo characterization of novel water-soluble dithio-bisphosphine 99mTc complexes.
Nuclear medicine and biology 1997;24(7):685-91.
1997: Li N; Struttman M; Higginbotham C; Grall A J; Skerlj J F; Vollano J F; Bridger S A; Ochrymowycz L A; Ketring A R; Abrams M J; Volkert W A
Biodistribution of model 105Rh-labeled tetradentate thiamacrocycles in rats.
Nuclear medicine and biology 1997;24(1):85-92.
1996: Berning D E; Katti K V; Singh P R; Higgenbotham C; Reddy V S; Volkert W A
In vitro and in vivo characterization of a 99mTc complex with tris(hydroxymethyl)phosphine (THP).
Nuclear medicine and biology 1996;23(5):617-22.
1996: Pandurangl R S; Karra S R; Kuntz R R; Volkert W A
Preservation of immunoreactivity in the photolabeling of the B72.3 human antibody.
Photochemistry and photobiology 1996;64(1):100-5.
1996: Venkatesh M; Goswami N; Volkert W A; Schlemper E O; Ketring A R; Barnes C L; Jurisson S
An Rh-105 complex of tetrathiacyclohexadecane diol with potential for formulating bifunctional chelates.
Nuclear medicine and biology 1996;23(1):33-40.
1995: Singh P R; Lusiak P; Volkert W A; Ketring A R; Holmes R A; Katti K V
Transition metal chemistry of main group hydrazides, Part 14: Evaluation of new Tc-99m chelates of thiol functionalized phosphorus hydrazides.
Nuclear medicine and biology 1995;22(7):849-57.
1995: Pandurangi R S; Karra S R; Kuntz R R; Volkert W A
High efficiency photolabeling of human serum albumin and human gamma-globulin with [14C]methyl 4-azido-2,3,5,6-tetrafluorobenzoate.
Bioconjugate chemistry 1995;6(5):630-4.
1995: Pandurangi R S; Kuntz R R; Volkert W A
Photolabeling of human serum albumin by 4-azido-2-([14C]-methylamino) trifluorobenzonitrile. A high-efficiency, long wavelength photolabel.
Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 1995;46(4):233-9.
1994: Singh P R; Katti K K; Katti K V; Corlija M; Ketring A R; Volkert W A; Holmes R R
A new 99mTc-complex with a germanium-hydrazide (GeTH) ligand.
Nuclear medicine and biology 1994;21(8):1115-8.
1994: Pillai M R; Schlemper E O; Volkert W A
Some observations on the instability of 99mTc-complexes of propylene amine oxime (PnAO).
Nuclear medicine and biology 1994;21(7):997-1003.
1994: Pillai M R; John C S; Lo J M; Troutner D E; Corlija M; Volkert W A; Holmes R A
99mTc-complexes of a pentadentate amine-oxime ligand.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1994;38(3):527-31.
1992: Singh P R; Corlija M; Troutner D E; Ketring A R; Volkert W A
Synthesis, characterization and biodistribution studies of a neutral-lipophilic Tc-99m N3S2 chelate.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(7):791-5.
1992: Roth C A; Hoffman T J; Corlija M; Volkert W A; Holmes R A
The effect of ligand structure on glutathione-mediated decomposition of propylene amine oxime derivatives.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1992;19(7):783-90.
1992: Farhanghi M; Holmes R A; Volkert W A; Logan K W; Singh A
Samarium-153-EDTMP: pharmacokinetic, toxicity and pain response using an escalating dose schedule in treatment of metastatic bone cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(8):1451-8.
1992: Corlija M; Katti K V; Volkert W A; Hoffman T J; Higginbotham C; Holmes R A
Formation of a stable 99mTc-tri-hydrazidophosphine oxide (99mTc-THP) chelate.
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1992;36(3):296-300.
1992: Johnson J C; Langhorst S M; Loyalka S K; Volkert W A; Ketring A R
Calculation of radiation dose at a bone-to-marrow interface using Monte Carlo modeling techniques (EGS4)
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1992;33(4):623-8.
1992: Hoffman T J; Volkert W A; Corlija M; McKenzie E H; Chaplin S B; Oberle P A; Holmes R A
Evaluation of alkylated derivatives of 99mTc-propylene amine oxime (99mTc-PnAO).
Journal of nuclear biology and medicine (Turin, Italy : 1991) 1992;36(1):46-51.
1991: Volkert W A; Goeckeler W F; Ehrhardt G J; Ketring A R
Therapeutic radionuclides: production and decay property considerations.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(1):174-85.
1991: Tubergen K; Corlija M; Volkert W A; Holmes R A
Sensitivity of technetium-99m-d,1-HMPAO to radiolysis in aqueous solutions.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1991;32(1):111-5.
1991: Ghiron J; Volkert W A; Garlich J; Holmes R A
Determination of lesion to normal bone uptake ratios of skeletal radiopharmaceuticals by QARG (quantitative autoradiography).
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(2):235-40.
1991: Corlija M; Volkert W A; John C S; Pillai M R; Lo J M; Troutner D E; Holmes R A
Biolocalization and cell labeling properties of neutral-lipophilic 99mTc-amine-phenol chelates.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1991;18(2):167-72.
1990: Lattimer J C; Corwin L A; Stapleton J; Volkert W A; Ehrhardt G J; Ketring A R; Anderson S K; Simon J; Goeckeler W F
Clinical and clinicopathologic response of canine bone tumor patients to treatment with samarium-153-EDTMP.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(8):1316-25.
1990: Volkert W A; Hoffman T J
Advances in radiopharmaceuticals for brain imaging with single-photon emission computed tomography.
Current opinion in radiology 1990;2(4):556-8.
1990: Lattimer J C; Corwin L A; Stapleton J; Volkert W A; Ehrhardt G J; Ketring A R; Hewett J E; Simon J; Goeckeler W F
Clinical and clinicopathologic effects of samarium-153-EDTMP administered intravenously to normal beagle dogs.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1990;31(5):586-93.
1989: Singh A; Holmes R A; Farhangi M; Volkert W A; Williams A; Stringham L M; Ketring A R
Human pharmacokinetics of samarium-153 EDTMP in metastatic cancer.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1989;30(11):1814-8.
1988: Hoffman T J; Corlija M; Chaplin S B; Volkert W A; Holmes R A
Retention of [99mTc]-d,l-HM-PAO in rat brain: an autoradiographic study.
Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 1988;8(6):S38-43.
1988: Hung J C; Corlija M; Volkert W A; Holmes R A
Kinetic analysis of technetium-99m d,1-HM-PAO decomposition in aqueous media.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1988;29(9):1568-76.
1988: Hoffman T J; Volkert W A; Holmes R A
Microcomputer-based digital image analysis system for quantitative autoradiography.
American journal of physiologic imaging 1988;3(2):81-90.
1987: Logan K W; Volkert W A; Holmes R A
Radiation dose calculations in persons receiving injection of samarium-153 EDTMP.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(4):505-9.
1987: Goeckeler W F; Edwards B; Volkert W A; Holmes R A; Simon J; Wilson D
Skeletal localization of samarium-153 chelates: potential therapeutic bone agents.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(4):495-504.
1987: Neirinckx R D; Canning L R; Piper I M; Nowotnik D P; Pickett R D; Holmes R A; Volkert W A; Forster A M; Weisner P S; Marriott J A
Technetium-99m d,l-HM-PAO: a new radiopharmaceutical for SPECT imaging of regional cerebral blood perfusion.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1987;28(2):191-202.
1987: Franz J; Freeman G M; Barefield E K; Volkert W A; Ehrhardt G J; Holmes R A
Labeling of antibodies with 64Cu using a conjugate containing a macrocyclic amine chelating agent.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1987;14(5):479-84.
1987: Franz J; Volkert W A; Barefield E K; Holmes R A
The production of 99mTc-labeled conjugated antibodies using a cyclam-based bifunctional chelating agent.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1987;14(6):569-72.
1986: Goeckeler W F; Troutner D E; Volkert W A; Edwards B; Simon J; Wilson D
153Sm radiotherapeutic bone agents.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(4):479-82.
1986: Chaplin S B; Oberle P A; McKenzie E H; Hoffman T J; Volkert W A; Holmes R A; Canning L R; Pickett R D; Nowotnik D P; Neirinckx R D
Regional cerebral uptake and retention of 99mTc-tetramethyl- and pentamethyl-propyleneamine oxime chelates.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(3):261-7.
1986: Volkert W A; Edwards B; Simon J; Wilson D A; McKenzie E H; Oberle P; Holmes R A
In vivo skeletal localization properties of 99mTc complexes of large phosphonate ligands.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1986;13(1):31-7.
1985: Holmes R A; Chaplin S B; Royston K G; Hoffman T J; Volkert W A; Nowotnik D P; Canning L R; Cumming S A; Harrison R C; Higley B
Cerebral uptake and retention of 99Tcm-hexamethylpropyleneamine oxime (99Tcm-HM-PAO).
Nuclear medicine communications 1985;6(8):443-7.
1985: McKenzie E H; Volkert W A; Holmes R A
Biodistribution of [14C]PnAO in rats.
International journal of nuclear medicine and biology 1985;12(2):133-4.
1984: Troutner D E; Volkert W A; Hoffman T J; Holmes R A
A neutral lipophilic complex of 99mTc with a multidentate amine oxime.
The International journal of applied radiation and isotopes 1984;35(6):467-70.
1984: Volkert W A; McKenzie E H; Hoffman T J; Troutner D E; Holmes R A
The behavior of neutral amine oxime chelates labelled with Tc at tracer level.
International journal of nuclear medicine and biology 1984;11(3-4):243-6.
1984: Ketring A R; Troutner D E; Hoffman T J; Stanton D K; Volkert W A; Holmes R A
Biodistribution of lipophilic 99mTc complexes of cyclam derivatives.
International journal of nuclear medicine and biology 1984;11(2):113-9.
1984: Volkert W A; Hoffman T J; Seger R M; Troutner D E; Holmes R A
99mTc-propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical.
European journal of nuclear medicine 1984;9(11):511-6.
1983: Ehrhardt G J; Volkert W; Goeckeler W F; Kapsch D N
A new Cd-115 leads to In-115m radionuclide generator.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1983;24(4):349-52.
1980: Troutner D E; Simon J; Ketring A R; Volkert W; Holmes R A
Complexing of Tc-99m with cyclam: concise communication.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1980;21(5):443-8.

Sign-in to see more